Trial record 5 of 7 for:
"small fiber neuropathy" OR "small nerve fiber neuropathy"
Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by JFK Medical Center.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Dr Charles Porbeni, JFK Medical Center
First received: January 31, 2012
Last updated: April 10, 2012
Last verified: February 2012
This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.
||Observational Model: Case-Only
Time Perspective: Prospective
||Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy
Primary Outcome Measures:
- Neuropathic Pain Questionnaire [ Time Frame: After 2 months ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Secondary Outcome Measures:
- QSART & ANSAR testing [ Time Frame: After 2 months ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||May 2012 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years to 75 Years
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Clinic patients at JFK Med CTR
- Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy
- Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01524666
|JFK Medical Center
|Edison, New Jersey, United States, 07712 |
|Contact: Karna D Sherwood, M.D. 732-321-7010 KSherwood@JFKHealth.org |
Dr Charles Porbeni
||Michael Rosenber, M.D.
||JFK Medical Center
||Dr Charles Porbeni, Research Coordinator, JFK Medical Center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 31, 2012
||April 10, 2012
||United States: Institutional Review Board
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 21, 2014
Peripheral Nervous System Diseases
Nervous System Diseases
Peripheral Vascular Diseases